AVAna Maria Burga Vega

Ana Maria Burga Vega

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ana Maria Burga Vega has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Tara Hayes Constant

    Carolyn Bain, Tara Hayes Constant, Ines Contreras, Jose Jeronimo, and Vivien Tsu, PATH, Seattle, WA; and Ana Maria Burga Vega, Instituto Regional de Enfermedades Neoplasicas - Norte, Trujillo, Peru

    2 shared publications
  • Anya Romanoff

    Department of Global Health, University of Washington, Seattle

    1 shared publication
  • Benjamin O. Anderson

    Department of Surgery and Global Health Medicine University of Washington Seattle Washington USA

    1 shared publication
  • Carolyn Bain

    Carolyn Bain, Tara Hayes Constant, Ines Contreras, Jose Jeronimo, and Vivien Tsu, PATH, Seattle, WA; and Ana Maria Burga Vega, Instituto Regional de Enfermedades Neoplasicas - Norte, Trujillo, Peru

    1 shared publication
  • Ines Contreras

    Carolyn Bain, Tara Hayes Constant, Ines Contreras, Jose Jeronimo, and Vivien Tsu, PATH, Seattle, WA; and Ana Maria Burga Vega, Instituto Regional de Enfermedades Neoplasicas - Norte, Trujillo, Peru

    1 shared publication
  • Jose Jeronimo

    Carolyn Bain, Tara Hayes Constant, Ines Contreras, Jose Jeronimo, and Vivien Tsu, PATH, Seattle, WA; and Ana Maria Burga Vega, Instituto Regional de Enfermedades Neoplasicas - Norte, Trujillo, Peru

    1 shared publication

Latest Publications

  • Open Access

    Model for Early Detection of Breast Cancer in Low-Resource Areas: The Experience in Peru

    by Carolyn Bain, Tara Hayes Constant, Ines Contreras, Ana Maria Burga Vega, Jose Jeronimo, Vivien Tsu

    Purpose: Late-stage breast cancer detection should be something of the past; however, it is still all too common in low-resource areas, including Peru, where 57% of women diagnosed with cancer are diagnosed at stage III or IV disease. Early detection of breast cancer is feasible in low-resource semirural and rural areas where mammography is rarely accessible. Methods: PATH collaborated with Peruvian health institutions at local, regional, and national levels to design and implement a model of care for the early detection of breast cancer in Peru. The model includes training health promoters for community outreach, professional midwives in clinical breast exam, doctors to perform fine-needle aspiration biopsy sampling with ultrasound to triage, and patient navigators to ensure patients follow through with treatment. Results: In a northern region of Peru, 400 individuals, including health promoters, midwives, doctors, and volunteers, received early-detection training in two phases. In Peru, local health professionals continue to refine and improve methods and materials using locally available resources, and the Peruvian health information system now includes specific breast cancer detection categories. Despite challenges and limited resources, the model is effective, and partnership with government health administrations improves health systems and benefits the population. Conclusion: Given the absence of screening mammography, the public health challenge is to bring breast cancer early detection and diagnostic services closer to women’s homes and to ensure appropriate follow-up and care. The model is eminently transferable with appropriate adaptation and should now be tested in other settings within and outside of Peru.


  • Open Access

    Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru

    by Anya Romanoff, Tara Hayes Constant, Kay M. Johnson, Manuel Cedano Guadiamos, Ana María Burga Vega, Joseph Zunt, Benjamin O. Anderson

    In their updated guidelines, the American Cancer Society “does not recommend clinical breast examination (CBE) for breast cancer screening among average-risk women at any age.”1(p 1608) This recommendation assumes that women have access to and are undergoing mammographic screening and should not be presumed to apply in settings where mammographic screening is lacking.2,3 Because population-based mammographic screening is impractical in most of the world, most breast cancers in low- and middle-income countries (LMICs) are initially identified on the basis of clinical signs and symptoms.4,5 In LMICs, the systematic implementation of CBE may play a crucial role in the early diagnosis of breast cancer by finding breast cancers at earlier stages or heightening women’s awareness of breast health concerns so that women present for evaluation earlier in their disease.